Cascader Completes Seed Funding Round

Cascader, a medical technology company based in the United Kingdom, has completed a seed funding round to advance its ophthalmic artificial intelligence platform. The startup focuses on developing AI tools for the early detection and management of eye diseases, including age-related macular degeneration, as well as broader applications in oculomics.

Investors

The funding round was led by Topcon Healthcare, a provider of eye care technology and solutions that has supported the company since its inception.

Cascader Use of Funds

Cascader will use the capital to transition its artificial intelligence technologies into clinical use. Specifically, the funding will support the progression of its initial products toward market launch, the expansion of its team, and the continued development of healthcare AI tools for eye care and systemic disease diagnostics.

About Cascader

Founded as a spinout from a partnership involving Moorfields Eye Hospital NHS Foundation Trust, Topcon Healthcare, and UCL Ventures, Cascader translates AI research into clinical applications. The company builds on over a decade of research from the UCL Institute of Ophthalmology and Moorfields Eye Hospital, utilizing deep learning to analyze medical imaging for more accurate disease detection.

Funding Details

Company Website: https://cascader.ai

Company: Cascader
Raised: Undisclosed
Round: Seed
Funding Date: September 22, 2026
Lead Investor: Topcon Healthcare
Software Category: Healthcare AI
Source: https://eyewire.news/news/cascader-completes-seed-funding-round-led-by-topcon-healthcare-to-advance-ophthalmic-ai